Zepp Health Gross Margin 2017-2026 | ZEPP
Current and historical gross margin for Zepp Health (ZEPP) over the last 10 years. The current gross profit margin for Zepp Health as of June 30, 2026 is %.
| Zepp Health Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $0.28B | $0.11B | 38.27% |
| 2026-03-31 | $0.27B | $0.10B | 37.87% |
| 2025-12-31 | $0.26B | $0.10B | 37.84% |
| 2025-09-30 | $0.23B | $0.09B | 36.75% |
| 2025-06-30 | $0.20B | $0.07B | 37.00% |
| 2025-03-31 | $0.18B | $0.07B | 37.91% |
| 2024-12-31 | $0.18B | $0.07B | 38.25% |
| 2024-09-30 | $0.21B | $0.08B | 37.38% |
| 2024-06-30 | $0.25B | $0.09B | 35.63% |
| 2024-03-31 | $0.30B | $0.09B | 30.87% |
| 2023-12-31 | $0.35B | $0.09B | 26.14% |
| 2023-09-30 | $0.42B | $0.09B | 22.41% |
| 2023-06-30 | $0.50B | $0.10B | 19.32% |
| 2023-03-31 | $0.58B | $0.11B | 18.61% |
| 2022-12-31 | $0.60B | $0.12B | 19.33% |
| 2022-09-30 | $0.70B | $0.14B | 19.35% |
| 2022-06-30 | $0.82B | $0.17B | 20.32% |
| 2022-03-31 | $0.83B | $0.18B | 21.16% |
| 2021-09-30 | $1.05B | $0.22B | 20.67% |
| 2021-06-30 | $1.13B | $0.24B | 20.80% |
| 2021-03-31 | $1.01B | $0.21B | 20.75% |
| 2020-12-31 | $0.99B | $0.21B | 20.79% |
| 2020-09-30 | $0.95B | $0.21B | 22.26% |
| 2020-06-30 | $0.88B | $0.21B | 23.75% |
| 2020-03-31 | $0.87B | $0.21B | 24.48% |
| 2019-12-31 | $0.84B | $0.21B | 25.15% |
| 2019-09-30 | $0.70B | $0.18B | 25.86% |
| 2019-06-30 | $0.59B | $0.16B | 26.40% |
| 2019-03-31 | $0.56B | $0.15B | 26.31% |
| 2018-12-31 | $0.53B | $0.14B | 25.90% |
| 2018-09-30 | $0.48B | $0.21B | 43.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.065B | $0.259B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |